A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

Summary

This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine RAP-219 Long- term safety and open-label antiseizure activity in patients with Refractory Focal Epilepsy.

Timeline

Start

2025-12-15

Primary completion

2028-02-03

Completion

2028-02-03

Drugs

Indications